Gilead Sciences preparing to sell senior notes in six tranches

By Aleesia Forni

Virginia Beach, Sept. 9 – Gilead Sciences Inc. announced its plan to price senior notes in six tranches, according a 424B5 filed with the Securities and Exchange Commission on Wednesday.

BofA Merrill Lynch and J.P. Morgan Securities LLC are the joint bookrunners.

Proceeds will be used for general corporate purposes.

The biopharmaceutical company is based in Foster City, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.